Home > Boards > US OTC > Biotechs > Fortress BioTechnology (FBIO)

Analysts projecting this baby is at $7.50 in

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
AgSEC Member Profile
 
Followed By 13
Posts 1,147
Boards Moderated 0
Alias Born 07/23/12
160x600 placeholder
Notice of Effectiveness (effect) Edgar (US Regulatory) - 11/23/2020 6:03:19 AM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 11/9/2020 5:17:18 PM
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 11/9/2020 5:13:07 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/9/2020 4:38:44 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/9/2020 4:22:29 PM
Avenue Therapeutics Receives Complete Response Letter from the FDA for IV Tramadol GlobeNewswire Inc. - 10/12/2020 6:30:10 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/25/2020 6:37:45 PM
Avenue Therapeutics Announces Publication of a Review of IV Tramadol GlobeNewswire Inc. - 9/9/2020 8:00:10 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/1/2020 8:35:02 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/1/2020 8:32:47 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 8/28/2020 8:49:51 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/28/2020 8:16:20 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/28/2020 8:10:07 AM
Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp) Edgar (US Regulatory) - 8/24/2020 8:02:30 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 8/24/2020 8:01:24 AM
Avenue Therapeutics Reports Second Quarter 2020 Financial Results and Recent Corporate Highlights GlobeNewswire Inc. - 8/14/2020 7:30:10 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/10/2020 4:36:51 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/10/2020 4:04:04 PM
Avenue Therapeutics Announces Publication of Phase 3 Bunionectomy Study Results GlobeNewswire Inc. - 7/21/2020 8:30:10 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/19/2020 5:02:06 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 6/12/2020 5:02:20 PM
Avenue Therapeutics Announces Publications in Peer-Reviewed Journals GlobeNewswire Inc. - 6/5/2020 8:30:10 AM
Avenue Therapeutics to Host Virtual Annual Meeting of Stockholders GlobeNewswire Inc. - 5/29/2020 8:30:10 AM
Avenue Therapeutics Reports First Quarter 2020 Financial Results and Recent Corporate Highlights GlobeNewswire Inc. - 5/11/2020 7:30:10 AM
Avenue Therapeutics Announces Presentation of IV Tramadol E-Posters GlobeNewswire Inc. - 4/23/2020 8:30:10 AM
AgSEC   Thursday, 07/11/19 01:21:28 PM
Re: None
Post # of 125 
Analysts projecting this baby is at $7.50 in the next 12 months with a low of $4.00 and a high of $11.00. I’m thinking this goes way above $10. FBIO

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences